glp-1 obesity drug news today oct 2025 CVS deal puts Lilly on equal footing with Novo GLP-1 Receptor Agonists Obesity Drugs

Mechanisms of amylin/leptin synergy in rodent models

For calcium imaging studies, male Naval Medical Research Institute (NMRI) mice (Taconic Biosciences, BomTac:NMRI) were used (aged 1828 days)

Europe Market Analysis Europe acts as the regulatory-intensive adoption zone, characterized by health technology assessment requirements, national reimbursement negotiations, and guideline-driven prescribing patterns

Overall, middle-income markets in Asia and Latin America are emerging as key drivers of global market expansion as treatment access improves and physician familiarity with GLP-1 medications increases

We found that, from a healthcare perspective, use of SGLT2is is probably cost-effective in both populations

AKKERMANSIA PROBIOTICThe powerful GLP-1 booster features a potent 20 Billion TFU of Akkermansia muciniphila to help naturally stimulate your body's own GLP-1 production